Major US health systems expect to offer Alzheimer’s drug Leqembi in a few months
By Julie Steenhuysen and Deena Beasley CHICAGO (Reuters) – Five
leqembi
Eisai files for full FDA approval for Alzheimer’s drug Leqembi
(Reuters) – Japanese drugmaker Eisai Co Ltd said on Saturday